Advanced search
Publication Cover
Renal Failure Volume 46, 2024 - Issue 1
Submit an article Journal homepage
535
Views
0
CrossRef citations to date
0
Altmetric
Acute Kidney Injury

The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients

Mohamed Adel Abd Elaziza Tropical Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptView further author information
,
Asmaa Mustafa Gouda Elewab Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Alexandria, EgyptView further author information
,
Dina Zaki Mohamed Zaki Abdel Hamidc Clinical Pharmacist at Alexandria Hepatology, Gastroenterology and Fever Hospital, EgyptView further author information
,
Nohier Essam Soliman Ahmed Hassand Clinical Pharmacist at Zamzam Hospital, Alexandria, EgyptView further author information
,
Éva Csongrádie Faculty of Medicine, University of Debrecen, Debrecen, HungaryView further author information
,
Emad Hamdy Hamouda Mohammedf Lecturer of Critical Care, Faculty of Medicine, Alexandria University, Alexandria, EgyptView further author information
&
Mohammed Abdel Gawadg Nephrology Unit, Internal Medicine Department, School of Medicine, Newgiza (NGU) University, Giza, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0708-8626View further author information
ORCID Icon show all
Article: 2346284 | Received 27 Dec 2023, Accepted 17 Apr 2024, Published online: 17 May 2024

References

  • Su Y, Yan R, Duan Z, et al. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China. J Med Virol. 2013;85(3):1–6. doi: 10.1002/jmv.23486.
  • Seo YS, Jung ES, An H, et al. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int. 2009;29(10):1521–1527. doi: 10.1111/j.1478-3231.2009.02105.x.
  • Cholongitas E, Shusang V, Marelli L, et al. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther. 2007;26(7):969–978. doi: 10.1111/j.1365-2036.2007.03443.x.
  • Belcher JM, Sanyal AJ, Peixoto AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology. 2014;60(2):622–632. doi: 10.1002/hep.26980.
  • Yap DY, Seto WK, Fung J, et al. Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis. Dig Liver Dis. 2017;49(2):202–206. doi: 10.1016/j.dld.2016.11.001.
  • Tandon P, James MT, Abraldes JG, et al. Relevance of new definitions to incidence and prognosis of acute kidney injury in hospitalized patients with cirrhosis: a retrospective population-based cohort study. PLoS One. 2016;11(8):e0160394. doi: 10.1371/journal.pone.0160394.
  • El-Makarem M-RA, et al. Do old urinary biomarkers have a place in the new definition of hepatorenal syndrome in the Egyptian cirrhotic patients? A single-center experience. Egypt Liver Journal. 2022;12(1):23.
  • Geng J, et al. The value of kidney injury molecule 1 in predicting acute kidney injury in adult patients: a systematic review and Bayesian meta-analysis. J Transl Med. 2021;19(1):1–13.
  • Qasem AA, Farag SE, Hamed E, et al. Urinary biomarkers of acute kidney injury in patients with liver cirrhosis. ISRN Nephrology. 2014;2014:1–7. doi: 10.1155/2014/376795.
  • Allegretti ASJH. NGAL in AKI and cirrhosis—ready for prime time? Hepatology. 2023;77(5):1472–1474. doi: 10.1002/hep.32807.
  • Fagundes C, Pépin M-N, Guevara M, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol. 2012;57(2):267–273. doi: 10.1016/j.jhep.2012.03.015.
  • Verna EC, Brown RS, Farrand E, et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci. 2012;57(9):2362–2370. doi: 10.1007/s10620-012-2180-x.
  • Ariza X, Solà E, Elia C, et al. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. PLoS One. 2015;10(6):e0128145. doi: 10.1371/journal.pone.0128145.
  • Jaques DA, Spahr L, Berra G, et al. Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study. Nephrology (Carlton). 2019;24(2):170–180. doi: 10.1111/nep.13226.
  • Huelin P, Solà E, Elia C, et al. Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study. Hepatology. 2019;70(1):319–333. doi: 10.1002/hep.30592.
  • Solé C, Ma AT, Solà E, et al. Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome. Liver Int. 2021;41(11):2729–2732. doi: 10.1111/liv.15069.
  • Gambino C, et al. Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury. Hepatology. 2023;77(5):1630–1638.
  • Cowland JB, Borregaard NJG. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics. 1997;45(1):17–23. doi: 10.1006/geno.1997.4896.
  • Manfredi MA, Zurakowski D, Rufo PA, et al. Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(8):1091–1096. doi: 10.1002/ibd.20419.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.